Published in Phytother Res on July 26, 2013
Hypothermia in mouse is caused by adenosine A1 and A3 receptor agonists and AMP via three distinct mechanisms. Neuropharmacology (2016) 0.75
A1 Adenosine Receptor Activation Modulates Central Nervous System Development and Repair. Mol Neurobiol (2016) 0.75
Memory enhancing activity of Glycyrrhiza glabra in mice. J Ethnopharmacol (2004) 1.51
Energetics of nanocrystalline TiO2. Proc Natl Acad Sci U S A (2002) 1.43
Partial agonistic action of clozapine at dopamine D2 receptors in dopamine depleted animals. Psychopharmacology (Berl) (1998) 1.41
Prescription monitoring of anti-hypertensive drug utilisation at the Panjab University Health Centre in India. Singapore Med J (2004) 1.23
Possible analgesic and anti-inflammatory interactions of aspartame with opioids and NSAIDs. Indian J Exp Biol (2005) 1.18
Autonomously replicating single-copy episomes in Trypanosoma brucei show unusual stability. EMBO J (1993) 1.16
Resveratrol, a polyphenolic phytoalexin, attenuates diabetic nephropathy in rats. Pharmacology (2005) 1.15
Sildenafil-induced peripheral analgesia and activation of the nitric oxide-cyclic GMP pathway. Brain Res (2001) 1.10
On the antinociceptive effect of fluoxetine, a selective serotonin reuptake inhibitor. Brain Res (2001) 1.05
Differential anxiolytic effects of neurosteroids in the mirrored chamber behavior test in mice. Brain Res (1997) 1.04
Evaluation of learning and memory mechanisms employing elevated plus-maze in rats and mice. Prog Neuropsychopharmacol Biol Psychiatry (1992) 1.04
Effect of alpha2 agonists clonidine, guanfacine and B-HT 920 on gastric acid secretion and ulcers in rats. Arch Int Pharmacodyn Ther (1985) 1.02
Possible role of nitric oxide in the nootropic and antiamnesic effects of neurosteroids on aging- and dizocilpine-induced learning impairment. Brain Res (1998) 1.00
Comparative brain cholinesterase-inhibiting activity of Glycyrrhiza glabra, Myristica fragrans, ascorbic acid, and metrifonate in mice. J Med Food (2006) 1.00
Microbial synthesis of semiconductor CdS nanoparticles, their characterization, and their use in the fabrication of an ideal diode. Biotechnol Bioeng (2002) 1.00
Sex and estrous cycle-dependent changes in neurosteroid and benzodiazepine effects on food consumption and plus-maze learning behaviors in rats. Pharmacol Biochem Behav (1999) 0.98
Antinociceptive and anti-inflammatory effects of Tanacetum parthenium L. extract in mice and rats. J Ethnopharmacol (1999) 0.98
Influence of biomass and gold salt concentration on nanoparticle synthesis by the tropical marine yeast Yarrowia lipolytica NCIM 3589. Colloids Surf B Biointerfaces (2009) 0.96
Improvement of mouse memory by Myristica fragrans seeds. J Med Food (2004) 0.96
Resveratrol and curcumin suppress immune response through CD28/CTLA-4 and CD80 co-stimulatory pathway. Clin Exp Immunol (2007) 0.95
Fluoxetine suppresses morphine tolerance and dependence: modulation of NO-cGMP/DA/serotoninergic pathways. Methods Find Exp Clin Pharmacol (2003) 0.95
Effect of a herbal psychotropic preparation, BR-16A (Mentat), on performance of mice on elevated plus-maze. Indian J Exp Biol (1991) 0.95
Comparative studies on the memory-enhancing actions of captopril and losartan in mice using inhibitory shock avoidance paradigm. Neuropeptides (2001) 0.92
Analgesic and anti-inflammatory effects of phosphodiesterase inhibitors. Indian J Exp Biol (2000) 0.91
Lipopolysaccharide-mediated immobility in mice: reversal by cyclooxygenase enzyme inhibitors. Methods Find Exp Clin Pharmacol (2001) 0.91
Sigma (sigma1) receptor mediated anti-depressant-like effects of neurosteroids in the Porsolt forced swim test. Neuroreport (1998) 0.90
Nitric oxide and major depression. Nitric Oxide (2011) 0.90
Brain renin angiotensin system (RAS) in stress-induced analgesia and impaired retention. Peptides (1999) 0.90
Involvement of nitric oxide (NO) signaling pathway in the antidepressant action of bupropion, a dopamine reuptake inhibitor. Eur J Pharmacol (2007) 0.89
Melatonin reversal of lipopolysacharides-induced thermal and behavioral hyperalgesia in mice. Eur J Pharmacol (2000) 0.89
Possible antioxidant mechanism in melatonin reversal of aging and chronic ethanol-induced amnesia in plus-maze and passive avoidance memory tasks. Free Radic Biol Med (2001) 0.89
Molecular interactions of ethanol with GABAergic system and potential of RO15-4513 as an ethanol antagonist. Pharmacol Biochem Behav (1988) 0.89
Effect of various antiepileptic drugs in a pentylenetetrazol-induced seizure model in mice. Methods Find Exp Clin Pharmacol (2009) 0.89
The role of GABA-A and mitochondrial diazepam-binding inhibitor receptors on the effects of neurosteroids on food intake in mice. Psychopharmacology (Berl) (1998) 0.89
The morphine sparing effect of physostigmine. Methods Find Exp Clin Pharmacol (1999) 0.87
Protective effects of nimesulide (COX Inhibitor), AKBA (5-LOX Inhibitor), and their combination in aging-associated abnormalities in mice. Methods Find Exp Clin Pharmacol (2005) 0.87
Possible involvement of sigma-1 receptors in the anti-immobility action of bupropion, a dopamine reuptake inhibitor. Fundam Clin Pharmacol (2008) 0.86
Melatonin enhances Th2 cell mediated immune responses: lack of sensitivity to reversal by naltrexone or benzodiazepine receptor antagonists. Mol Cell Biochem (2001) 0.86
Involvement of L-arginine-nitric oxide-cyclic guanosine monophosphate pathway in the antidepressant-like effect of venlafaxine in mice. Prog Neuropsychopharmacol Biol Psychiatry (2007) 0.85
Anti-inflammatory actions of clonidine, guanfacine and B-HT 920 against various inflammagen-induced acute paw oedema in rats. Arch Int Pharmacodyn Ther (1986) 0.85
Template-free ZnS nanorod synthesis by microwave irradiation. Nanotechnology (2008) 0.85
Titania nanoparticles synthesis in mesoporous molecular sieve MCM-41. J Colloid Interface Sci (2007) 0.85
Memory-strengthening activity of Glycyrrhiza glabra in exteroceptive and interoceptive behavioral models. J Med Food (2004) 0.85
The effects of neurosteroids on acquisition and retention of a modified passive-avoidance learning task in mice. Brain Res (1998) 0.85
Protective effect of quercetin on alcohol abstinence-induced anxiety and convulsions. J Med Food (2005) 0.85
Heat and other physiological stress-induced analgesia: catecholamine mediated and naloxone reversible response. Life Sci (1980) 0.85
Involvement of sigma-1 receptor modulation in the antidepressant action of venlafaxine. Neurosci Lett (2007) 0.84
Regulation of secretion of IL-4 and IgG1 isotype by melatonin-stimulated ovalbumin-specific T cells. Clin Exp Immunol (1998) 0.84
Involvement of cholinergic system in losartan-induced facilitation of spatial and short-term working memory. Neuropeptides (1998) 0.84
Evidence for GABA-BZ receptor modulation in short-term memory passive avoidance task paradigm in mice. Methods Find Exp Clin Pharmacol (1990) 0.84
Risperidone, an atypical antipsychotic enhances the antidepressant-like effect of venlafaxine or fluoxetine: possible involvement of alpha-2 adrenergic receptors. Neurosci Lett (2008) 0.84
Role of GABA-A and mitochondrial diazepam binding inhibitor receptors in the anti-stress activity of neurosteroids in mice. Psychopharmacology (Berl) (1996) 0.84
Rofecoxib, a selective cyclooxygenase-2 (COX-2) inhibitor increases pentylenetetrazol seizure threshold in mice: possible involvement of adenosinergic mechanism. Epilepsy Res (2007) 0.84
Anti-depressant action of melatonin in chronic forced swimming-induced behavioral despair in mice, role of peripheral benzodiazepine receptor modulation. Eur Neuropsychopharmacol (2000) 0.84
Antidepressant-like effect of 17beta-estradiol: involvement of dopaminergic, serotonergic, and (or) sigma-1 receptor systems. Can J Physiol Pharmacol (2008) 0.84
Differential role of dopamine receptor subtypes in thermoregulation and stereotypic behavior in naive and reserpinized rats. Arch Int Pharmacodyn Ther (1994) 0.83
Influence of intraventricular administration of norepinephrine, dopamine and 5-hydroxytryptamine on motor activity of rats. Indian J Med Res (1975) 0.83
New drug metabolism inhibitor of marine origin. J Pharm Sci (1978) 0.83
Estimation of adenosine and its major metabolites in brain tissues of rats using high-performance thin-layer chromatography-densitometry. J Chromatogr A (2008) 0.83
Purine nucleoside--mediated immobility in mice: reversal by antidepressants. Psychopharmacology (Berl) (1985) 0.83
Venlafaxine reverses chronic fatigue-induced behavioral, biochemical and neurochemical alterations in mice. Pharmacol Biochem Behav (2008) 0.83
Melatonin provides signal 3 to unprimed CD4(+) T cells but failed to stimulate LPS primed B cells. Clin Exp Immunol (2001) 0.83
Effect of purinergic substances on rectal temperature in mice: involvement of P1-purinoceptors. Arch Int Pharmacodyn Ther (1983) 0.82
Effect of Convolvulus pluricaulis Choisy and Asparagus racemosus Willd on learning and memory in young and old mice: a comparative evaluation. Indian J Exp Biol (2010) 0.82
Modulation of motor functions involving the dopaminergic system by AT1 receptor antagonist, losartan. Neuropeptides (1998) 0.82
Role of cysteinyl leukotrienes in nociceptive and inflammatory conditions in experimental animals. Eur J Pharmacol (2001) 0.82
5-HT2A receptor antagonists block MK-801-induced stereotypy and hyperlocomotion. Eur J Pharmacol (1998) 0.82
Dizocilpine, ketamine and ethanol reverse NMDA-induced EEG changes and convulsions in rats and mice. Indian J Physiol Pharmacol (1991) 0.81
Effect of addition of yohimbine (alpha-2-receptor antagonist) to the antidepressant activity of fluoxetine or venlafaxine in the mouse forced swim test. Pharmacology (2007) 0.81
Targeting oxidative stress, mitochondrial dysfunction and neuroinflammatory signaling by selective cyclooxygenase (COX)-2 inhibitors mitigates MPTP-induced neurotoxicity in mice. Prog Neuropsychopharmacol Biol Psychiatry (2011) 0.81
Effect of 5-HT1A and 5-HT2A/2C receptor modulation on neuroleptic-induced vacuous chewing movements. Eur J Pharmacol (2001) 0.81
Proconvulsant effects of neurosteroids pregnenolone sulfate and dehydroepiandrosterone sulfate in mice. Eur J Pharmacol (1998) 0.81
Involvement of dopamine D2 and 5-HT1A receptors in roxindole-induced antinociception. Indian J Exp Biol (1999) 0.81
Possible mechanisms of action in melatonin reversal of morphine tolerance and dependence in mice. Eur J Pharmacol (2000) 0.81
Involvement of dopamine (DA)/serotonin (5-HT)/sigma (sigma) receptor modulation in mediating the antidepressant action of ropinirole hydrochloride, a D2/D3 dopamine receptor agonist. Brain Res Bull (2007) 0.81
GABA-mediated modification of despair behavior in mice. Naunyn Schmiedebergs Arch Pharmacol (1989) 0.80
Melatonin reversal of DOI-induced hypophagia in rats; possible mechanism by suppressing 5-HT(2A) receptor-mediated activation of HPA axis. Brain Res (2000) 0.80
Naloxone-sensitive and GABAA receptor mediated analgesic response of benzodiazepines in mice. Methods Find Exp Clin Pharmacol (1987) 0.80
Rofecoxib, a selective cyclooxygenase-2 (COX-2) inhibitor potentiates the anticonvulsant activity of tiagabine against pentylenetetrazol-induced convulsions in mice. Inflammopharmacology (2006) 0.80
Systemic administration of adenosine ameliorates pentylenetetrazol-induced chemical kindling and secondary behavioural and biochemical changes in mice. Fundam Clin Pharmacol (2007) 0.80
Excitatory mechanisms in neuroleptic-induced vacuous chewing movements (VCMs): possible involvement of calcium and nitric oxide. Behav Pharmacol (2001) 0.80
Involvement of peripheral prostaglandins in formalin-induced nociceptive behaviours in the orofacial area of rats. Inflammopharmacology (2006) 0.80
Chronic neurosteroid treatment prevents the development of morphine tolerance and attenuates abstinence behavior in mice. Eur J Pharmacol (1997) 0.80
Reversal of morphine tolerance and dependence by melatonin: possible role of central and peripheral benzodiazepine receptors. Brain Res (1999) 0.80
Nitric oxide signaling pathway in the anti-convulsant effect of adenosine against pentylenetetrazol-induced seizure threshold in mice. Eur J Pharmacol (2008) 0.80
Role of D1/D2 dopamine and N-methyl-D-aspartate (NMDA) receptors in morphine tolerance and dependence in mice. Eur Neuropsychopharmacol (1995) 0.80
Possible involvement of prostaglandins in haloperidol-induced orofacial dyskinesia in rats. Eur J Pharmacol (2001) 0.79
Resveratrol, a polyphenolic phytoalexin attenuates thermal hyperalgesia and cold allodynia in STZ-induced diabetic rats. Indian J Exp Biol (2006) 0.79
Reversal by serotonergic agents of reserpine-induced hyperalgesia in rats. Eur J Pharmacol (1982) 0.79
Antinociceptive effect of sumatriptan in mice. Indian J Exp Biol (1998) 0.79
Development of neurosteroid-based novel psychotropic drugs. Prog Med Chem (2000) 0.79
Effects of MK-801 and ketamine on short-term memory deficits in passive avoidance step-down task paradigm in mice. Methods Find Exp Clin Pharmacol (1991) 0.79
Influence of antidepressant drugs on learning and memory paradigms in mice. Indian J Exp Biol (1996) 0.79
Pro-convulsant effect of cefazolin sodium against pentylenetetrazol- or picrotoxin-induced convulsions in mice. Indian J Exp Biol (2007) 0.79
Evidence for the presence of P1- and P2-purinoceptors in rat caecum. Arch Int Pharmacodyn Ther (1983) 0.79
Neurosteroid coadministration prevents development of tolerance and augments recovery from benzodiazepine withdrawal anxiety and hyperactivity in mice. Methods Find Exp Clin Pharmacol (1997) 0.79
Preferential inhibition of dizocilpine-induced hyperlocomotion by olanzapine. Eur J Pharmacol (1999) 0.79
Prevention of morphine discontinuation phenomenon in mice by ondansetron, a selective 5-HT3 antagonist. Methods Find Exp Clin Pharmacol (1996) 0.79
On the sleep promoting effects of BR-16A: interaction with GABAergic modulators. Indian J Exp Biol (2004) 0.79
Central nervous system depressant activities of melatonin in rats and mice. Indian J Exp Biol (1998) 0.79